4//SEC Filing
SOLAND DANIEL B 4
Accession 0001209191-22-035663
CIK 0001070494other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 8:21 PM ET
Size
7.9 KB
Accession
0001209191-22-035663
Insider Transaction Report
Form 4
SOLAND DANIEL B
Director
Transactions
- Award
Director Stock Options (Right to Buy)
2022-06-07+14,368→ 14,368 totalExercise: $18.27Exp: 2032-06-06→ Common Stock (14,368 underlying) - Award
Restricted Stock Units
2022-06-07+8,552→ 8,552 total→ Common Stock (8,552 underlying)
Footnotes (3)
- [F1]The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
- [F3]The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001318485
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 8:21 PM ET
- Size
- 7.9 KB